Dextera Surgical Inc. (fka DXTRQ)

[nlightn]

Dextera Surgical to Report Fiscal 2017 Second Quarter Financial Results on Tuesday, February 7, 2017

Today : Thursday 26 January 2017


Dextera Surgical Inc. (Nasdaq:DXTR) today announced that it will release financial results for its fiscal second quarter ended December 31, 2016, on Tuesday, February 7, 2017, after the markets close. Dextera Surgical’s management will hold a conference call at 4:30 p.m. Eastern Time to discuss financial results and provide an update on the company’s business.

Conference Call Details

To access the live conference call on February 7, 2017, at 4:30 p.m. Eastern Time via phone, please dial 844-419-1785 from the United States and Canada or 216-562-0472. The conference ID is 59554399. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately four hours after the call through February 14, 2017, and may be accessed by dialing 855-859-2056 from the United States and Canada or 404-537-3406 internationally. The replay passcode is 59554399.

To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company’s website at ir.dexterasurgical.com. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads.

The webcast is also being distributed through the Thomson StreetEvents Network. Institutional investors can access the call via Thomson StreetEvents at www.streetevents.com, a password-protected event management site.

About Dextera Surgical

Dextera Surgical (Nasdaq:DXTR) designs and manufactures proprietary stapling devices for minimally invasive surgical procedures. In the U.S., surgical staplers are routinely used in more than one million minimally invasive laparoscopic, video-assisted or robotic-assisted surgical procedures annually.

Dextera Surgical also markets the only automated anastomosis devices for coronary artery bypass graft (CABG) surgery on the market today: the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System. These products, sold by Dextera Surgical under the Cardica brand name, have demonstrated long-term reliable clinical performance for more than a decade.



View source version on businesswire.com: http://www.businesswire.com/news/home/20170126005904/en/

Dextera Surgical
Bob Newell, 650-331-7133
Vice President, Finance and Chief Financial Officer
[e-mail]